Related Experiment Video
Updated: Aug 12, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Methamphetamine-associated cardiomyopathy: an addiction medicine perspective
Vincenzo Somma1, Michael Osekowski1, Elizabeth Paratz1,2
1Department of Addiction Medicine, Department of Cardiology, St Vincent's Hospital Melbourne, Victoria, Melbourne, Australia.
Methamphetamine-associated cardiomyopathy (MaCM) is a serious heart condition linked to methamphetamine use. Abstinence is crucial for treatment, with addiction specialists aiding recovery.
Area of Science:
- Cardiology
- Toxicology
- Addiction Medicine
Background:
- Methamphetamine-associated cardiomyopathy (MaCM) is a significant cause of heart failure in methamphetamine users.
- It disproportionately affects a young population, leading to high morbidity and mortality.
- MaCM is the second leading cause of death among individuals with methamphetamine use disorder (MUD).
Approach:
- This review synthesizes current knowledge on MaCM pathogenesis.
- It summarizes recent recommendations for MaCM screening and treatment.
- The role of addiction medicine in managing MaCM patients is highlighted.
Key Points:
- Proposed pathological mechanisms of MaCM are explained.
- Current screening and treatment guidelines are reviewed.
- The importance of abstinence and addiction specialist referral is emphasized.
Conclusions:
- Effective MaCM management hinges on patient abstinence from methamphetamine.
- Medical therapies show limited efficacy without abstinence.
- Understanding MaCM risks and seeking addiction treatment are vital for patient outcomes.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy